Skip to main content
. 2024 Feb 8;9(2):196–208. doi: 10.1016/j.synbio.2024.01.012

Table 3.

Analysis of variance of a screening model for effecting variables on antibacterial activity tested against K. pneumonia using PBD.

Source DF * Seq SS Contribution Adj SS Adj MS F-Value P-Value
Model 4 676.58 97.74% 676.58 169.146 75.68 0
Linear 4 676.58 97.74% 676.58 169.146 75.68 0
Incubation time 1 35.02 5.06% 35.02 35.021 15.67 0.005
Inoculum size 1 38.52 5.56% 38.52 38.521 17.23 0.004
Yeast ext. 1 63.02 9.10% 63.02 63.021 28.2 0.001
Elicitation 1 540.02 78.01% 540.02 540.021 241.61 0
Error 7 15.65 2.26% 15.65 2.235
Total 11 692.23 100.00%
Coded Coefficients
Term Coef SE Coef 95% CI T-Value P-Value VIF
Constant 8.292 0.432 (7.271, 9.312) 19.21 0
Incubation time 1.708 0.432 (0.688, 2.729) 3.96 0.005 1
Inoculum size 1.792 0.432 (0.771, 2.812) 4.15 0.004 1
Yeast ext. 2.292 0.432 (1.271, 3.312) 5.31 0.001 1
Elicitation −6.708 0.432 (-7.729, −5.688) −15.54 0 1

aDF: Degrees of Freedom, Seq SS: Sequential Sum of Squares, Contribution: Contribution to the model, Adj SS: Adjusted Sum of Squares, Adj MS: Adjusted Mean Square, F-Value: F-Statistic, P-Value: Probability Value, Coef: Coefficient estimate, SE Coef: Standard error of the coefficient estimate, 95% CI: 95% confidence interval for the coefficient estimate, T-Value: The T-value for the hypothesis test of the coefficient being 0, VIF: Variance Inflation Factor.